Home » Topics » Disease categories and therapies » Immune

Immune
RSS

AMD-3100 rapidly mobilizes stem cells in phase I trial

Nov. 12, 2001

Quest Diagnostics, exclusive distributor of Vasogen's immune modulation therapy

Nov. 12, 2001

Wyeth Lederle Vaccines and RIVM collaborate on meningitis vaccine development

Nov. 12, 2001

Aventis prepares beta-carboline inhibitor of IKK which prolongs cardiac graft survival

Nov. 9, 2001

Vaccines for chronic diseases jointly researched by Novartis and Cytos

Nov. 7, 2001

Meningitis vaccines near commercialization in Canada

Nov. 7, 2001

Novartis seeks European marketing authorization for Myfortic

Nov. 7, 2001

Tanox designs anticomplement monoclonal antibodies for autoimmune and inflammatory diseases

Nov. 6, 2001

Ribi-529 adjuvant added to Corixa/Wyeth Lederle Vaccines license agreement

Nov. 6, 2001

TolerRx to advance lead product with completion of financing

Nov. 2, 2001

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...